Liver News and Research

RSS

Finding reliable health information online: an interview with Dr Andrew Boyden

The research was presented by pharmacists from the Calvary Public Hospital in Canberra, who looked at conversations that took place in selected parenting groups on Facebook.

22 Nov 2016

Women more susceptible to damaging effects of alcohol, says Houston Methodist expert

"One drink a day might be too much for a woman who has a genetic pre-disposition to cirrhosis of the liver," said Howard Monsour, M.D., chief of hepatology at Houston Methodist Hospital "One drink for a woman has about twice the effect as it does for the same amount consumed by a man."

22 Nov 2016

Low-calorie diet and exercise could improve kidney function in patients with NASH

Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring.

21 Nov 2016

New public-private partnership launches major health effort to reduce cancer in San Francisco

Cancer is the leading cause of death in San Francisco and costs patients, families and taxpayers hundreds of millions of dollars each year.

21 Nov 2016

Researchers move closer to creating functional bioartificial kidney

Investigators are getting closer to creating a functional bioartificial kidney, with advances being presented at ASN Kidney Week 2016 November 15-20 at McCormick Place in Chicago, IL.

21 Nov 2016

Molecules team up to maintain healthy level of fat in liver, study finds

As obesity rates rise in the United States, so does the incidence of liver diseases.

18 Nov 2016

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Proactive outreach to cirrhosis patients in a safety net health system successfully doubled their screening rates for liver cancer, UT Southwestern Medical Center researchers found.

18 Nov 2016

Alcohol to cause 135,000 cancer deaths over next 20 years, news report reveals

Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK.

18 Nov 2016

De-risking drug development free webinar from Envigo

De-risking represents a relatively new but developing strategy designed to quickly assess if a new drug has a liability. Knowing your compound’s risk for drug-to-drug interactions (DDI), drug induced liver injury (DILI) and metabolites in safety testing (MIST) early on in drug development, leads to greater confidence and added value on your molecule’s journey to market.

18 Nov 2016

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine.

17 Nov 2016

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

The first thing that is important to stress is that this is an area that we actually know very little about. What we generally think, rather than know, is that NTM has a lot in common with pulmonary tuberculosis.

17 Nov 2016

Experimental cancer imaging tool shows promise in illuminating brain tumors during surgery

An experimental cancer imaging tool that makes tumors glow brightly during surgery has shown promise again in a new Penn Medicine clinical study, this time in patients with brain cancer.

17 Nov 2016

Food restriction may be potential treatment strategy for certain types of cancers, research suggests

Could limiting food intake be a valid treatment strategy for certain types of cancers? New research in The FASEB Journal suggests "maybe."

16 Nov 2016

Crowdsourcing new prediction tool for better prognosis of metastatic castration-resistant prostate cancer

Knowing the likely course of cancer can influence treatment decisions. Now a new prediction model published today in Lancet Oncology offers a more accurate prognosis for a patient's metastatic castration-resistant prostate cancer.

16 Nov 2016

Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem’s unique and multifaceted mode of action.

15 Nov 2016

Statins can help prevent first time heart attacks, strokes in adults with cardiovascular risk factors

Cholesterol-lowering drugs help prevent heart attacks and strokes in adults with cardiovascular risk factors such as high cholesterol, high blood pressure, diabetes and smoking, but have not yet had a heart attack or stroke, according to a large-scale analysis of clinical trial data led by the OHSU Pacific Northwest Evidence-Based Practice Center.

14 Nov 2016

Length of telomeres may reveal if vitamin D and omega-3 supplements improve heart health, longevity

The length of your telomeres appears to be a window into your heart health and longevity, and scientists are measuring them to see if vitamin D and omega-3 supplements really improve both.

14 Nov 2016

Fraunhofer researchers use new deep learning approach to facilitate tumor measurement

Physicians have long used visual judgment of medical images to determine the course of cancer treatment.

14 Nov 2016

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

A new study presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases — found patients with hepatitis C who take direct-acting antiviral medication are at no higher risk for developing liver cancer than those who do not take the medication.

11 Nov 2016

Particular eating behaviors linked to lower odds of developing liver diseases

Particular eating behaviors may lower the risk of developing non-alcoholic fatty liver disease (NAFLD), according to research presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases.

11 Nov 2016

Liver News and Research

Finding reliable health information online: an interview with Dr Andrew Boyden

Women more susceptible to damaging effects of alcohol, says Houston Methodist expert

Low-calorie diet and exercise could improve kidney function in patients with NASH

New public-private partnership launches major health effort to reduce cancer in San Francisco

Researchers move closer to creating functional bioartificial kidney

Molecules team up to maintain healthy level of fat in liver, study finds

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Alcohol to cause 135,000 cancer deaths over next 20 years, news report reveals

De-risking drug development free webinar from Envigo

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

Getting drugs to bugs in NTM lung infections: an interview with Dr Jakko van Ingen

Experimental cancer imaging tool shows promise in illuminating brain tumors during surgery

Food restriction may be potential treatment strategy for certain types of cancers, research suggests

Crowdsourcing new prediction tool for better prognosis of metastatic castration-resistant prostate cancer

Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting

Statins can help prevent first time heart attacks, strokes in adults with cardiovascular risk factors

Length of telomeres may reveal if vitamin D and omega-3 supplements improve heart health, longevity

Fraunhofer researchers use new deep learning approach to facilitate tumor measurement

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

Particular eating behaviors linked to lower odds of developing liver diseases

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News